Pharmageddon"This meticulously documented book makes extraordinary claims with far-reaching intellectual and practical ramifications. It is the most powerful critique of the contemporary medical-industrial complex that I know."—Andrew T. Scull, author of Hysteria and Madness: A Very Short Introduction “This book shines a bright light on the pharmaceutical industry (and American healthcare) in the same way that Silent Spring called out the chemical industry and Unsafe at Any Speed called out the automobile industry. Pharmageddon is Healy's most important book to date. It will make a real contribution toward healing our sick system of pharmaceutical-driven medicine and helping doctors provide better care for their patients.”--Elizabeth Siegel Watkins, author of The Estrogen Elixir and On the Pill “In this startling book, David Healy argues that 'evidence-based' medicine—and a healthy dose of corrupt science—has led modern medicine off a cliff. His book is provocative, challenging, and informative, and ultimately it serves as a powerful manifesto for rethinking modern medicine.”--Robert Whitaker, author of Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America "Like a good detective story, Pharmageddon weaves together the history of modern medicine, the evolution of clinical trials and statistical analyses, changes in international patent laws, privatization of clinical research, blurring of the line between academics and industry, and the enabling role of medical journals. If you want to learn how to protect yourself (or your patients) from medical commercialism and how medical practice can be re-directed back toward its true mission, this book is a must read."—John Abramson, author of Overdosed America |
Other editions - View all
Common terms and phrases
academics American antibiotics antidepressants antipsychotics appeared asthma Avandia benefits biphosphonates bipolar disorder blockbuster blood sugars brand British cardiovascular cause century cholesterol cholesterol levels claims clinical trials clinicians company trials costs David Healy death depression diabetes disease doctors drug companies evidence evidence-based medicine faced fact ghostwriting GlaxoSmithKline guidelines happens hazards healthcare heart attacks illness increase increasingly insulin issue Journal of Psychiatry Kefauver’s lead Lilly linked Medical Journal ment mood stabilizer NEJM older drugs osteoporosis patients Paxil percent Pfizer pharma pharmaceutical companies pharmaceutical industry Pharmageddon physicians pill Pinel placebo practice prescribe prescription prescription-only status problems Prozac published randomized controlled trials rating scales regulators risk Risperdal schizophrenia scientific side effects SmithKline SSRIs statins statistically significant studies suicidal acts tests therapeutic tion tolbutamide treat treatment trial data Vioxx women Worcester York Zoloft Zyprexa